Union Medical Healthcare's sales contracts surged by 45% in the First Half of FY2017/18

[For Immediate Release] /

Union Medical Healthcare's sales contracts surged by 45% in the First Half of FY2017/18

(9 October 2017, Hong Kong) Union Medical Healthcare Limited ("Union Medical Healthcare" or the "Company"; together with its subsidiaries, the "Group", SEHK stock code: 2138), a leading medical aesthetic service provider in Hong Kong, announced that based on the latest assessment by the Board with reference to the preliminary unaudited consolidated management accounts of the Group currently available, the Group expects to record an increase of no less than 45% in total sales contracts for the six months ended 30 September 2017 as compared with the same period last year, which was mainly attributable to the Group's elevated quality of medical services and its expansion of service mix, leading to an increase in customer spending, in particular those of PRC customers.

Mr. Eddy Tang, Chairman, Executive Director and Chief Executive Officer of Union Medical Healthcare said, "Union Medical Healthcare has always been committed to establishing the highest standard in the industry. Whilst aggressive diversification of services scope was achieved by introducing segments such as dental services, comprehensive health screening and chiropractic services, the Group's cross-selling capabilities has been proven from the synergistic effect that was being created. Our outstanding sales performance is a testament to our insightful operative strategies of offering one-stop medical, health and beauty services. We will continue to enhance our product mix and actively capture opportunities for market consolidation to enlarge our market share, as to strengthen the Group's leading position in the market for aesthetic medical services to generate better returns for our investors."

- End -

About Union Medical Healthcare Limited Union Medical Healthcare is principally engaged in the provision of one-stop aesthetic medical, beauty and health management solutions with 46 clinics and servicing centres across Hong Kong, the PRC and Macao as at 30 September 2017. In 2016, the Group obtained the Hong Kong Top Service Brand and opened re:HEALTH, a one-stop health management centre, to provide a full range of services and products, including comprehensive health screening, health product and health management services. The Group is the largest aesthetic medical service provider in Hong Kong in terms of revenue. The Group ranked first in Hong Kong from 2012 to 2016 in terms of the number of aesthetic injection procedures performed involving utilization of the top-six revenue-generating aesthetic medications in Hong Kong; and was the Black Diamond Provider of the transparent orthodontic device for teeth alignment, Invisalign(R), in 2015 and 2016. The Group has successfully built DR REBORN, a well-recognized brand in Hong Kong, with the reputation of being a premier provider of aesthetic medical services in Hong Kong.

For further information, please contact: iPR Ogilvy & Mather Callis Lau / Molisa Lau / Maggie Chui / Francesca Yeung Tel: (852) 2136 6952 / 2136 6953 / 2136 8059 / 3920 7639 Fax: (852) 3170 6606 Email: umh@iprogilvy.com